Literature DB >> 3974656

Effect of rifampin on chloramphenicol levels.

C G Prober.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3974656     DOI： 10.1056/NEJM198503213121212

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  9 in total

Review 1.  Clinically significant interactions with drugs used in the treatment of tuberculosis.

Authors:  W W Yew
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

Review 2.  Pharmacokinetic drug interactions with rifampicin.

Authors:  K Venkatesan
Journal:  Clin Pharmacokinet       Date:  1992-01       Impact factor: 6.447

Review 3.  Clinical pharmacokinetics of antibacterial drugs in neonates.

Authors:  C M Paap; M C Nahata
Journal:  Clin Pharmacokinet       Date:  1990-10       Impact factor: 6.447

4.  Interaction between chloramphenicol and acetaminophen.

Authors:  J S Spika; D J Davis; S R Martin; K Beharry; J Rex; J V Aranda
Journal:  Arch Dis Child       Date:  1986-11       Impact factor: 3.791

Review 5.  Pharmacokinetic interactions with rifampicin : clinical relevance.

Authors:  Mikko Niemi; Janne T Backman; Martin F Fromm; Pertti J Neuvonen; Kari T Kivistö
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

6.  Two- and four-day rifampin chemoprophylaxis regimens induce oxidative metabolism.

Authors:  S M Borcherding; T L Bastian; T H Self; N Abou-Shala; B W LeDuc; R L Lalonde
Journal:  Antimicrob Agents Chemother       Date:  1992-07       Impact factor: 5.191

Review 7.  Clinical pharmacokinetics in infants and children. A reappraisal.

Authors:  G L Kearns; M D Reed
Journal:  Clin Pharmacokinet       Date:  1989       Impact factor: 6.447

Review 8.  Avoidance and management of adverse reactions to antituberculosis drugs.

Authors:  A M Patel; J McKeon
Journal:  Drug Saf       Date:  1995-01       Impact factor: 5.606

Review 9.  Tuberculosis and pharmacological interactions: A narrative review.

Authors:  Niccolò Riccardi; Diana Canetti; Paola Rodari; Giorgio Besozzi; Laura Saderi; Marco Dettori; Luigi R Codecasa; Giovanni Sotgiu
Journal:  Curr Res Pharmacol Drug Discov       Date:  2020-12-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.